ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-CD105 Antibody [ENG/1327] - BSA and Azide free (A251613)

Mouse monoclonal [ENG/1327] antibody to CD105 for Flow Cytometry, IF and WB.

Alternative Formats and ConjugatesAlternative Formats

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 5-8 business days.
Name
Anti-CD105 Antibody [ENG/1327] - BSA and Azide free
Description
Mouse monoclonal [ENG/1327] antibody to CD105.
Specificity
This antibody is a specific and sensitive marker for tumor angiogenesis as it labels only newly-formed blood vessels and may serve as a prognostic marker for Prostate Adenocarcinoma, and cancers of the lung, stomach, breast, and brain.
Applications
Flow Cytometry, IF, WB
Dilutions
Flow Cytometry: 0.5-1 µg/million cells, IF: 1-2 µg/ml, WB: 1-2 µg/ml
Reactivity
Human
Immunogen
Recombinant fragment, around amino acids 74-251, of human Endoglin protein. The exact sequence is proprietary.
Host
Mouse
Clonality
Monoclonal
Clone ID
ENG/1327
Isotype
IgG1
Light Chains
kappa
Conjugate

Unconjugated

Purification
Protein A/G chromatography.
Concentration
1 mg/ml
Molecular Weight
84 kDa
Product Form
Liquid
Formulation
Supplied in 10mM Phosphate Buffered Saline; without Sodium Azide and carrier free.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
General Notes
This monoclonal antibody is also available in a different formulation with BSA and Sodium Azide - Anti-CD105 Antibody [ENG/1327] (A248431).
Synonyms
END, Endoglin, ENG
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Anti-CD105 Antibody [ENG/1327] - BSA and Azide free (A251613)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-CD105 Antibody [ENG/1327] - BSA and Azide free (A251613)

Proteins predicted to interact with CD105

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.8% Relevancy Score
99.7% Relevancy Score
99.6% Relevancy Score
99.5% Relevancy Score
97.9% Relevancy Score
97.7% Relevancy Score
96.9% Relevancy Score
94.1% Relevancy Score